Literature DB >> 8499793

Managing advanced multiple sclerosis.

R W Teasell1.   

Abstract

Multiple sclerosis is one of the most common neurologic conditions in Canada. Many individuals with MS eventually develop the progressive form of the disease. The neurologic and psychosocial manifestations of the later stages of MS are numerous. Family physicians ought to have some understanding of patients with advanced MS and some knowledge of how to manage them.

Entities:  

Mesh:

Year:  1993        PMID: 8499793      PMCID: PMC2379662     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  52 in total

1.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  Clinical studies on multiple sclerosis. I. Presentation of an incidence material from Gothenburg.

Authors:  T Broman; O Andersen; L Bergmann
Journal:  Acta Neurol Scand       Date:  1981-01       Impact factor: 3.209

3.  Prevalence of multiple sclerosis in Saskatoon.

Authors:  W J Hader
Journal:  Can Med Assoc J       Date:  1982-08-15       Impact factor: 8.262

4.  Sexual dysfunction in multiple sclerosis.

Authors:  M L Valleroy; G H Kraft
Journal:  Arch Phys Med Rehabil       Date:  1984-03       Impact factor: 3.966

5.  Hyperbaric oxygen therapy in chronic stable multiple sclerosis: double-blind study.

Authors:  G D Harpur; R Suke; B H Bass; M J Bass; S B Bull; L Reese; J H Noseworthy; G P Rice; G C Ebers
Journal:  Neurology       Date:  1986-07       Impact factor: 9.910

6.  A double-blind comparative clinical trial of floctafenine and four other analgesics conducted in general practice.

Authors:  D M Lomas; J Gay; R N Midha; D L Postlethwaite
Journal:  J Int Med Res       Date:  1976       Impact factor: 1.671

7.  Increased energy cost of walking in multiple sclerosis: effect of spasticity, ataxia, and weakness.

Authors:  R Olgiati; J M Burgunder; M Mumenthaler
Journal:  Arch Phys Med Rehabil       Date:  1988-10       Impact factor: 3.966

8.  Multiple sclerosis after age 50.

Authors:  J Noseworthy; D Paty; T Wonnacott; T Feasby; G Ebers
Journal:  Neurology       Date:  1983-12       Impact factor: 9.910

9.  Depression and neuroticism in multiple sclerosis.

Authors:  G Colombo; M Armani; E Ferruzza; C Zuliani
Journal:  Ital J Neurol Sci       Date:  1988-12

10.  The spectrum of depression in multiple sclerosis. An approach for clinical management.

Authors:  R B Schiffer
Journal:  Arch Neurol       Date:  1987-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.